Bostentan is a: (DNB June 2012)
|A||Serotonin uptake inhibitor|
|B||Endothelin receptor antagonist|
a. The U.S. Food and Drug Administration (FDA) has announced to approval of bosentan- the 1st oral medication for improving the exercise ability and decreasing clinical worsening of patients with the rare disorder of pulmonary hypertension.
b. (Bosentan) is a revolutionary advancement in the treatment of pulmonary hypertension.
c. According to the FDA, Tracleer effectively blocks the action of endothelin. Endothelin narrows blood vessels and elevates blood pressure.